Kingsley Lawrence D's Form 4 filing
IDEXX Laboratories Inc (IDXX) · filed Sep 9, 2026
- Accession no.
- 0000874716-26-000127
- Filed
- Sep 9, 2026, 5:00 PM ET
- Trade date
- Sep 4, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.17M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kingsley Lawrence DCIK 0001301427 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | Common Stock | MOption exerciseAcquired | +2,203 | $114.17 | +$251,516.51 | 11,771 | Direct | |
| Sep 4, 2026 | Common Stock | SSaleDisposed | −2,203 | $532.08 | −$1,172,177.97 | 9,568 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | Common Stock | MOption exerciseDisposed | −2,203 | – | – | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.